Body mass index (BMI) is a predictor for response to neoadjuvant chemotherapy in women with localized breast cancer aged 35 years or younger.

dc.contributor.author	Valero, V
dc.contributor.author	Arun, B
dc.contributor.author	Kau, SW
dc.contributor.author	Buzdar, A
dc.contributor.author	Hortobagyi, GN
dc.contributor.author	Eralp, Y
dc.contributor.author	Smith, TL
dc.date.accessioned	2021-03-05T07:43:42Z
dc.date.available	2021-03-05T07:43:42Z
dc.identifier.citation	Eralp Y., Smith T., Kau S., Valero V., Buzdar A., Hortobagyi G., Arun B., "Body mass index (BMI) is a predictor for response to neoadjuvant chemotherapy in women with localized breast cancer aged 35 years or younger.", 40th Annual Meeting of the American-Society-of-Clinical-Oncology, Louisiana, Amerika Birleşik Devletleri, 5 - 08 Haziran 2004, cilt.22
dc.identifier.other	vv_1032021
dc.identifier.other	av_954c8678-6866-4728-a124-f804bac688ad
dc.identifier.uri	http://hdl.handle.net/20.500.12627/100527
dc.language.iso	eng
dc.subject	Sağlık Bilimleri
dc.subject	Dahili Tıp Bilimleri
dc.subject	İç Hastalıkları
dc.subject	Onkoloji
dc.subject	Klinik Tıp (MED)
dc.subject	Tıp
dc.subject	Klinik Tıp
dc.subject	ONKOLOJİ
dc.title	Body mass index (BMI) is a predictor for response to neoadjuvant chemotherapy in women with localized breast cancer aged 35 years or younger.
dc.type	Bildiri
dc.contributor.department	, ,
dc.identifier.volume	22
dc.contributor.firstauthorID	129946

Bu öğenin dosyaları:

Dosyalar	Boyut	Biçim	Göster
Bu öğe ile ilişkili dosya yok.